Interferon-β is a potent promoter of nerve growth factor production by astrocytes

Journal of Neurochemistry

Volumn 69, Issue 3, 1997, Pages 939-946

  Boutros, Tarek ^a   Croze, Ed ^b   Yong, Voon Wee ^a,c  

^a MCGILL UNIVERSITY   (Canada)

^b BAYER AG   (Germany)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

Glia; Neurotrophic factors; Oligodendrocytes; Remyelination

Indexed keywords

BETA INTERFERON; NERVE GROWTH FACTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL PROLIFERATION; DOSE RESPONSE; DRUG EFFECT; GROWTH STIMULATION; MOUSE; NERVE CELL GROWTH; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS REGULATION;

ANIMALIA;

EID: 0030756916     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.69030939.x     Document Type: Article

References (50)

1. Abreu S. L. (1982) Suppression of experimental allergic encephalomyelitis by interferon. Immunol. Commun. 11, 1-7.
2. Abreu S. L. (1985) Interferon in experimental allergic encephalomyelitis (EAE): effects of exogenous interferon on the antigen-enhanced adoptive transfer of EAE. Int. Arch. Allergy Appl. Immunol. 76, 302-307.
3. Althaus H. H., Klöppner S., Schmidt-Schultz T., and Schwartz P. (1992) Nerve growth factor induces proliferation and enhances fibre regeneration in oligodendrocytes isolated from adult pig brain. Neurosci. Lett. 135, 219-223.
4. Arendt T., Bruckner M. K., Krell T., Pagliusi S., Kruska L., and Heumann R. (1995) Degeneration of rat cholinergic basal forebrain neurons and reactive changes in nerve growth factor expression after chronic neurotoxic injury. II. Reactive expression of NGF gene in astrocytes. Neuroscience 65, 647-659.
5. Arnason B. G. W., Dayat A., Qu Z. X., Jensen M. A., Genc K., and Reder A. T. (1996) Mechanisms of action of interferon-β in multiple sclerosis. Springer Semin. Immunopathol. 18, 125-147.
6. Arnold D. L., Matthews P. M., Francis G., and Antel J. (1990) Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: assessment of the load of disease. Magn. Reson. Med. 14, 154-159.
7. Awatsuji H., Furukawa Y., Hirota M., Furukawa S., and Hayashi K. (1995) Interferons suppress nerve growth factor synthesis as a result of interference with cell growth in astrocytes cultured from neonatal mouse brain. J. Neurochem. 64, 1476-1482.
8. Barde Y.-A. (1989) Trophic factors and neuronal survival. Neuron 2, 1525-1534.
9. Barna P. B., Chou S. M., Jacobs B., Yen-Lieberman B., and Ransohoff R. M. (1989) Interferon-β impairs induction of HLA-DR antigen expression in cultured adult human astrocytes. J. Neuroimmunol. 23, 45-53.
10. Byravan S., Foster L. M., Phan T., Verity N., and Campagnoni A. T. (1994) Murine oligodendroglial cells express nerve growth factor. Proc. Natl. Acad. Sci. USA 91, 8812-8816.
11. Carswell S. (1993) The potential for treating neurodegenerative disorders with NGF-inducing compounds. Exp. Neurol. 124, 36-42.
12. Casaccia-Bonnefil P., Carter B. D., Dobrowsky R. T., and Chao M. V. (1996) Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75. Nature 383, 716-719.
13. Cohen R. I., Marnur R., Norton W. T., Mehler M. F., and Kassler J. A. (1996) Nerve growth factor and neurotrophin-3 differentially regulate the proliferation and survival of developing rat brain oligodendrocytes. J. Neurosci. 16, 6433-6442.
14. Davies A. M. (1994) The role of neurotrophins in the developing nervous system. J. Neurobiol. 25, 1334-1348.
15. Davies S. E. C., Newcombe J., Williams S. R., McDonald W. I., and Clark J. B. (1995) High resolution proton NMR spectroscopy of multiple sclerosis lesions. J. Neurochem. 64, 742-748.
16. Hayashi M. (1996) Neurotrophins and the primate central nervous system: a minireview. Neurochem. Res. 21, 739-747.
17. Holtzman D. M., Kilbridge J., Li Y., Cunningham E. T. Jr., Lenn N. J., Clary D. O., Reichardt L. F., and Mobley W. C. (1995) TrkA expression in the CNS: evidence for the existence of several novel NGF-responsive CNS neurons. J. Neurosci. 15, 1567-1576.
18. IFNβ Multiple Sclerosis Study Group (1993) Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 43, 655-661.
19. IFNβ Multiple Sclerosis Study Group and the University of British Columbia MS/MRI Analysis Group (1995) Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. Neurology 45, 1277-1285.
20. Jacobs L., Cookfair D., Rudick R., Herndon R. M., Richert J. R., Salazar A. M., Fischer J. S., Goodkin D. E., and Crang D. (1996) Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. Ann. Neurol. 39, 285-294.
21. Khan O. A., Xia Q., Bever C. T., Johnson K. P., Panitch H. S., and Dhib-Jalbut S. (1996) Interferon beta-1b serum levels in multiple sclerosis patients following subcutaneous administration. Neurology 46, 1639-1643.
22. Kimata H., Yoshida A., Ishioka C., Kusunoki T., Hosoi S., and Mikawa H. (1991) Nerve growth factor specifically induces human IgG4 production. Eur. J. Immunol. 21, 137-141.
23. Kumar S., Peña L. A., and de Vellis J. (1993) CNS glial cells express neurotrophin receptors whose levels are regulated by NGF. Mol. Brain Res. 17, 163-168.
24. Luckenbill-Edds L., van Horn C., and Greene L. A. (1979) Fine structure of initial outgrowth of processes induced in a pheochromocytoma cell line (PC12) by nerve growth factor. J. Neurocytol. 8, 493-511.
25. McLaurin J. and Yong V. W. (1995) Oligodendrocytes and myelin, in Neurologic Clinics on Multiple Sclerosis (Antel J. P., ed), pp. 23-49. W. B. Saunders, Philadelphia.
26. McLaurin J., Antel J. P., and Yong V. W. (1995) Immune and non-immune actions of interferon-β-1b on primary human neural cells. Multiple Sclerosis 1, 10-19.
27. Neveu I., Jehan F., Houlgatte R., Wion D., and Brachet P. (1992) Activation of nerve growth factor synthesis in primary glial cells by phorbol 12-myristate 13-acetate: role of protein kinase C. Brain Res. 570, 316-322.
28. Noronha A., Toscas A., and Jensen M. A. (1993) Interferon-β decreases T cell activation and interferon-γ production in multiple sclerosis. J. Neuroimmunol. 46, 145-154.
29. Oderfeld-Nowak B., Bacia A., Gradkowska M., Fusco M., Vantani G., Leon A., and Aloe L. (1992) In vivo activated brain astrocytes may produce and secrete nerve growth factor-like molecules. Neurochem. Int. 21, 455-461.
30. Oh L. Y. S. and Yong V. W. (1996) Astrocytes promote process outgrowth by adult human oligodendrocytes in vitro through interaction between bFGF and astrocyte extracellular matrix. Glia 17, 237-253.
31. Olson L. (1993) NGF and the treatment of Alzheimer's disease. Exp. Neurol. 124, 5-15.
32. 11C-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer patient (case report). J. Neural Transm. Park. Dis. Dement. Sect. 4, 79-95.
33. Otten U., Ehrhard P., and Peck R. (1989) Nerve growth factor induces growth and differentiation of human B lymphocytes. Proc. Natl. Acad. Sci. USA 86, 10059-10063.
34. Paty D. W., Li D. K., UBC MS/MRI Study Group, and the IFNβ Multiple Sclerosis Study Group (1993) Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 43, 662-667.
35. Petty B. G., Cornblath D. R., Adornato B. T., Chaudhry V., Flexner C., Wachsman M., Sinicropi D., Burton L. E., and Peroutka S. J. (1994) The effects of systemically administered recombinant human growth factor in healthy human subjects. Ann. Neurol. 36, 244-246.
36. Prineas J. W. and Connell F. (1978) The fine structure of chronically active multiple sclerosis plaques. Neurology 28, 68-75.
37. Pshenichkin S. P. and Wise B.C. (1995) Okadaic acid increases nerve growth factor secretion, mRNA stability, and gene transcription in primary cultures of cortical astrocytes. J. Biol. Chem. 270, 5994-5999.
38. Pshenichkin S. P., Szekely A. M., and Wise B. C. (1994) Transcriptional and posttranscriptional mechanisms involved in the interleukin-1, steroid, and protein kinase C regulation of nerve growth factor in cortical astrocytes. J. Neurochem. 63, 419-428.
39. Ser (Betaseron). J. Interferon Cyt. Res. 15, 31-37.
40. Santambrogio L., Benedetti M., Chao M. V., Muzaffar R., Kulig K., Gabellini N., and Hochwald G. (1994) Nerve growth factor production by lymphocytes. J. Immunol. 153, 4488-4495.
41. Stüve O., Dooley N. P., Uhm J. H., Antel J. P., Williams G., and Yong V. W. (1996) Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloprotease-9. Ann. Neurol. 40, 853-863.
42. Thoenen H., Bandtlow C., and Heumann R. (1987) The physiological function of nerve growth factor in the central nervous system: comparison with the periphery. Rev. Physiol. Biochem. Pharmacol. 109, 145-178.
43. Thorpe L. W. and Perez-Polo J. R. (1987) The influence of nerve growth factor on the in vitro proliferative response of rat spleen lymphocytes. J. Neurosci. Res. 18, 134-139.
44. Tischler A. S. and Greene L. A. (1975) Nerve growth factor-induced process formation by cultured rat pheochromocytoma cells. Nature 258, 341-342.
45. Weinstock-Guttman B., Ransohoff R. M., Kindel R. P., and Rudick R. A. (1995) The interferons: biological effects, mechanisms of action, and use in multiple sclerosis. Ann. Neurol. 37, 7-15.
46. Weller R. O. (1985) Pathology of multiple sclerosis, in McAlpine's Multiple Sclerosis (Matthews W. B., Acheson E. D., Batchelor J. R., and Weller R. O., eds), pp. 301-343. Churchill Livingstone, Edinburgh.
47. Yong V. W. (1996) Cytokines, astrogliosis and neurotrophism following CNS trauma, in Cytokines and the CNS (Ransohoff R. M. and Beneviste E. N., eds), pp. 309-327. Plenum Press, New York.
48. Yong V. W. and Antel J. P. (1996) Culture of glial cells from human brain biopsies, in Protocols for Neural Cell Culture (Fedoroff S. and Richardson A., eds), pp. 157-172. Humana Press, Totowa, New Jersey.
49. Yong V. W., Tejada-Berges T., Goodyer C. G., Antel J. P., and Yong F. P. (1992) Differential proliferative response of human and mouse astrocytes to gamma-interferon. Glia 6, 269-280.
50. Yu M., Nishiyama A., Trapp B. D., and Tuohy V. K. (1996) Interferon-β inhibits progression of relapsing-remitting experimental autoimmune encephalomyelitis. J. Neuroimmunol. 64, 91-100.